Baxter International (MIL:1BAX) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1BAX Baxter International Inc MIL:1BAX
34 GF Score
Price €18.15
GF Value €31.26
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Baxter International FFO per Share?

FFO per Share only applies to REITs.

MIL:1BAX
34GF Score
Baxter International Inc MIL:1BAX
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Baxter International (MIL:1BAX) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of €18.15 is trading 42% below its estimated GF Value™ of €31.26. GuruFocus considers Baxter International to be Possible Value Trap.

Key valuation signals for MIL:1BAX:

  • FFO per Share:
  • GF Value™: €31.26 vs. price of €18.15 (42% below fair value)
  • GF Score™: 34/100 with 7 warning signs

No single metric tells the full story. See the MIL:1BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
34GF Score

Get the complete analysis for MIL:1BAX

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.15
Price
€31.26
GF Value